Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms-Reference-Cited by-同舟云学术

Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms

Published:2019-02-20 Issue:6 Volume:137 Page:981-1001
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Masnata Maria,Sciacca Giacomo,Maxan Alexander,Bousset Luc,Denis Hélèna L.,Lauruol Florian,David Linda,Saint-Pierre Martine,Kordower Jeffrey H.,Melki Ronald,Alpaugh Melanie,Cicchetti Francesca

Funder

Centre national de la recherche scientifique

Canadian Institutes of Health Research

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s00401-019-01973-6/fulltext.html

Reference59 articles.

1. Akhtar S, Wenborn A, Brandner S, Collinge J, Lloyd SE (2011) Sex effects in mouse prion disease incubation time. PLoS One 6:e28741. https://doi.org/10.1371/journal.pone.0028741

2. Allen E, Carlson KM, Zigmond MJ, Cavanaugh JE (2011) L-DOPA reverses motor deficits associated with normal aging in mice. Neurosci Lett 489:1–4. https://doi.org/10.1016/j.neulet.2010.11.054

3. Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13:93–110. https://doi.org/10.1007/s10339-011-0430-z

4. Ast A, Buntru A, Schindler F, Hasenkopf R, Schulz A, Brusendorf L, Klockmeier K, Grelle G, McMahon B, Niederlechner H et al (2018) mHTT seeding activity: a marker of disease progression and neurotoxicity in models of Huntington’s disease. Mol Cell 71(675–688):e676. https://doi.org/10.1016/j.molcel.2018.07.032

5. Bates G (2003) Huntingtin aggregation and toxicity in Huntington’s disease. Lancet 361:1642–1644. https://doi.org/10.1016/S0140-6736(03)13304-1

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington’s disease cases;Neurobiology of Disease;2024-08

2. A method for the analysis of the oligomerization profile of the Huntington’s disease-associated, aggregation-prone mutant huntingtin protein by isopycnic ultracentrifugation;Frontiers in Molecular Biosciences;2024-06-27

3. Brain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions;International Journal of Molecular Sciences;2024-04-25

4. Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development;Expert Review of Neurotherapeutics;2024-02-07

5. Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse;Frontiers in Molecular Neuroscience;2024-01-03